Clinical Trials Browser

Phase 2/3 × Hormone Receptor Positive HER-2 Negative Breast Cancer × Clear all

NCT02692755 2021-09-28

PALINA

Phase 2/3 Completed

35 enrolled 12 charts

Hormone Receptor Positive HER-2 Negative Breast Cancer